Armata Pharmaceuticals, Inc. (ARMP) Key Statistics
$3.64AMEX: ARMPMarket Cap $135.34M
Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for Armata Pharmaceuticals, Inc. (ARMP), each with what it measures. Figures are trailing twelve months or the most recent reported period.
Valuation
Metric
Value
P/E ratioShare price divided by earnings per share.
-0.58
P/B ratioShare price divided by book value per share.
-0.49
P/S ratioMarket value divided by annual revenue.
34.49
PEG ratioP/E divided by the earnings growth rate.
0.01
EV / EBITDAEnterprise value against earnings before interest, tax, depreciation and amortisation.
-2.39
EV / RevenueEnterprise value against annual revenue.
122.39
Earnings yieldEarnings per share as a percentage of the share price — the inverse of P/E.
-192.31%
Free cash flow yieldFree cash flow as a percentage of market value.
-22.67%
Profitability
Metric
Value
Gross marginRevenue left after the direct cost of goods sold.
68.23%
Operating marginRevenue left after operating costs.
-620.00%
Net marginRevenue left after every cost, including tax and interest.
-95.54%
Return on equityProfit as a percentage of shareholders’ equity.
89.70%
Return on assetsProfit as a percentage of total assets.
-213.65%
Return on capital employedOperating profit against the capital the business uses.
25.40%
Financial health
Metric
Value
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.
0.11
Quick ratioThe same, excluding inventory.
0.11
Cash ratioCash alone against current liabilities.
1.00
Debt to equityTotal borrowings against shareholders’ equity.
-1.36
Debt to assetsTotal borrowings against total assets.
3.74
Interest coverageHow many times operating profit covers the interest bill.
-1.90
Per share and size
Metric
Value
Earnings per shareProfit attributable to each share.
$-4.80
Book value per shareShareholders’ equity divided by shares outstanding.
$0.00
Shares outstandingShares currently issued.
0
Market capitalisationShare price times shares outstanding.
$135.34M
Enterprise valueMarket value plus net debt — what it would cost to buy the business outright.
$403.78M
EmployeesReported headcount.
60
Dividend
Metric
Value
Dividend yieldAnnual dividend as a percentage of the share price.
0.00%
Armata Pharmaceuticals, Inc. (ARMP) statistics — frequently asked questions
What is Armata Pharmaceuticals, Inc.'s P/E ratio?
Armata Pharmaceuticals, Inc. (ARMP) trades on a price-to-earnings ratio of -0.58. A negative P/E means the company reported a loss, so the ratio is not a meaningful valuation measure.
What is Armata Pharmaceuticals, Inc.'s return on equity?
Armata Pharmaceuticals, Inc. (ARMP) reports a return on equity of 89.70%, meaning it generated that much profit for every dollar of shareholders' equity.
How much debt does Armata Pharmaceuticals, Inc. carry?
Armata Pharmaceuticals, Inc. (ARMP) has a debt-to-equity ratio of -1.36, which compares total borrowings with shareholders' equity.
What is Armata Pharmaceuticals, Inc.'s profit margin?
Armata Pharmaceuticals, Inc. (ARMP) keeps -95.54% of revenue as net profit after every cost, including tax and interest.